Illumina CLIA lab subscribes to Clarity LIMS to augment existing informatics infrastructure
News Mar 03, 2013
GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs, has announced that the Illumina Clinical Services Laboratory has signed a subscription license agreement for Clarity LIMS. Under the agreement, Clarity LIMS, alongside internally developed systems within the CLIA-certified, CAP-accredited laboratory at Illumina, will be used to support Illumina's TruSight Individual Genome Sequencing (IGS) test.
"In the clinical laboratory environment, informatics tools to support compliance, such as the data and workflow enforcement features offered in Clarity LIMS, are crucial to ensuring high quality throughout the laboratory process," said Marc Laurent, Director of Commercial Services for Illumina. "We are confident that Clarity LIMS will help us to maintain our high quality standards and serve physicians and patients as the demand for our sequencing services grow."
Clarity LIMS is an intuitive lab management system that combines information management essentials for CLIA-certified and other regulated labs with a clear and simple interface. Specifically, Clarity LIMS assists these organizations with workflow enforcement, adherence to standard operating procedures and management of the specific complexities associated with next-generation sequencing (NGS). All of these capabilities can be implemented within a few weeks, making Clarity LIMS unparalleled in the industry.
"We are pleased to be part of the Illumina CLIA laboratory's' robust informatics ecosystem," says Michael Ball, CEO of GenoLogics. "An increasing number of CLIA laboratories are taking advantage of our flexible Clarity LIMS subscription licensing to support the growing sequencing services business."
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Leibniz Supercomputing Centre Introduces Plans for its Next-generation SuperMUC MachineNews
Leadership at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences and Humanities announced today that they have signed a contract with Intel and Lenovo to build SuperMUC-NG, the next generation of the centre's leading-edge supercomputers.READ MORE
New Computational Strategies Could Help Peptide Therapeutics DevelopmentNews
New computational strategies reported this week might help realize the promise of peptide-based drugs. Peptides are similar to protein molecules, but differ in their smaller size, structure and functions.READ MORE